CLOV stock price recorded a 2% gain on optimism around cost-control measures announced by Clover Health. This uptick aligns with recent trends in small-cap healthcare stocks benefiting from reimbursement rate stability. Its Non-Insurance services segment includes the Clover Assistant platform that helps doctors detect and manage chronic diseases earlier by providing personalized data-driven insights for their patients. Add Quiver Quantitative to your preferred sources on Google CLOV stock price is projected to test the $1.25 level if upcoming membership data exceeds estimates. Some analysts are revising target prices upward by 8%, citing improved actuarial margins.